Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

PetMed Express, Inc. - Common Stock (NQ:PETS)

1.750 -0.020 (-1.13%)

Streaming Delayed Price Updated: 1:00 PM EST, Nov 28, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	106,464
Open	1.800
Bid (Size)	1.630 (3,500)
Ask (Size)	2.000 (1,000)
Prev. Close	1.770
Today's Range	1.745 - 1.860
52wk Range	1.590 - 6.850
Shares Outstanding	21,013,848
Dividend Yield	68.57%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Keep an eye on the top gainers and losers in Thursday's session. ↗

November 13, 2025

Intrigued by the market activity one hour before the close of the markets on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

November 13, 2025

Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

Performance

YTD	-62.3%	-62.3%
1 Month	-32.4%	-32.4%
3 Month	-43.0%	-43.0%
6 Month	-52.7%	-52.7%
1 Year	-62.2%	-62.2%

More News

12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session ↗

November 13, 2025

Via Benzinga

Which stocks are gapping on Thursday? ↗

November 13, 2025

Via Chartmill

PETMED EXPRESS INVESTIGATION: Bragar Eagel & Squire, P.C. Reminds PetMed Express Investors of the Ongoing Investigation on Behalf of Stockholders

November 01, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

PETMED REMINDER: Bragar Eagel & Squire, P.C. Reminds PetMed Express Investors of the Ongoing Investigation on Behalf of Stockholders

October 15, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Securities Fraud Investigation Into PetMed Express, Inc. (PETS) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

October 10, 2025

From The Law Offices of Frank R. Cruz

Via Business Wire

PETMED INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating PetMed Express, Inc. on Behalf of PetMed Stockholders and Encourages Investors to Contact the Firm

September 08, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

August 17, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

August 13, 2025

From Pomerantz LLP

Via GlobeNewswire

12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session ↗

August 13, 2025

Via Benzinga

Get insights into the top gainers and losers of Tuesday's after-hours session. ↗

August 12, 2025

Via Chartmill

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

August 09, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

August 05, 2025

From Pomerantz LLP

Via GlobeNewswire

12 Consumer Discretionary Stocks Moving In Monday's After-Market Session ↗

August 04, 2025

Via Benzinga

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

August 01, 2025

From Pomerantz LLP

Via GlobeNewswire

12 Consumer Discretionary Stocks Moving In Monday's After-Market Session ↗

July 28, 2025

Via Benzinga

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

July 28, 2025

From Pomerantz LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C Continues Investigations on Behalf of Lineage, Proficient Auto, PetMed, and GeneDx and Encourages Investors to Contact the Firm

July 23, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

July 23, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

July 18, 2025

From Pomerantz LLP

Via GlobeNewswire

PETMED INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating PetMed Express, Inc. on Behalf of PetMed Stockholders and Encourages Investors to Contact the Firm

July 15, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

12 Consumer Discretionary Stocks Moving In Monday's After-Market Session ↗

July 14, 2025

Via Benzinga

Bragar Eagel & Squire, P.C Continues Investigations on Behalf of PetMed, GeneDx, Lineage, and Proficient Auto and Encourages Investors to Contact the Firm

July 14, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

July 14, 2025

From Pomerantz LLP

Via GlobeNewswire

Frequently Asked Questions

Is PetMed Express, Inc. - Common Stock publicly traded?

Yes, PetMed Express, Inc. - Common Stock is publicly traded.

What exchange does PetMed Express, Inc. - Common Stock trade on?

PetMed Express, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for PetMed Express, Inc. - Common Stock?

The ticker symbol for PetMed Express, Inc. - Common Stock is PETS on the Nasdaq Stock Market

What is the current price of PetMed Express, Inc. - Common Stock?

The current price of PetMed Express, Inc. - Common Stock is 1.750

When was PetMed Express, Inc. - Common Stock last traded?

The last trade of PetMed Express, Inc. - Common Stock was at 11/28/25 01:00 PM ET

What is the market capitalization of PetMed Express, Inc. - Common Stock?

The market capitalization of PetMed Express, Inc. - Common Stock is 36.77M

How many shares of PetMed Express, Inc. - Common Stock are outstanding?

PetMed Express, Inc. - Common Stock has 37M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.